These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38756652)

  • 1. Eosinophilic granulocytes as a potential prognostic marker for cancer progression and therapeutic response in malignant melanoma.
    Brand CL; Hunger RE; Seyed Jafari SM
    Front Oncol; 2024; 14():1366081. PubMed ID: 38756652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy.
    Moreira A; Leisgang W; Schuler G; Heinzerling L
    Immunotherapy; 2017 Jan; 9(2):115-121. PubMed ID: 28128709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic defense and inflammation in parasitic infections. The role of eosinophilic granulocytes].
    Ruitenberg EJ; Buys J; Elgersma A; Teppema JS
    Tijdschr Diergeneeskd; 1983 Jun; 108(12):488-91. PubMed ID: 6879581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IL-5 therapies for asthma.
    Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL5 therapies for asthma.
    Farne HA; Wilson A; Powell C; Bax L; Milan SJ
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010834. PubMed ID: 28933516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1).
    Cybulska-Stopa B; Kamińska-Winciorek G; Dyduch G
    Melanoma Res; 2020 Dec; 30(6):619-624. PubMed ID: 32809991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM; Lawson DH; Khan MK; Kudchadkar RR; Buchwald ZS
    Lancet Oncol; 2021 Dec; 22(12):1777-1786. PubMed ID: 34780711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors.
    Simon SCS; Hu X; Panten J; Grees M; Renders S; Thomas D; Weber R; Schulze TJ; Utikal J; Umansky V
    Oncoimmunology; 2020; 9(1):1727116. PubMed ID: 32117594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.
    de Joode K; Veenbergen S; Kransse C; Kortleve D; Debets R; Mathijssen RHJ; Joosse A; Schreurs MWJ; Van der Veldt AAM
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescence studies on eosinophilic granulocytes.
    Berretty PJ; Cormane RH
    Br J Dermatol; 1979 Sep; 101(3):309-14. PubMed ID: 389270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing roles of eosinophils in cancer.
    Simon SCS; Utikal J; Umansky V
    Cancer Immunol Immunother; 2019 May; 68(5):823-833. PubMed ID: 30302498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
    Chan KK; Magro C; Shoushtari A; Rudin C; Rotemberg V; Rossi A; Lezcano C; Carrino J; Fernandez D; Postow MA; Apollo A; Lacouture ME; Bass AR
    Oncologist; 2020 Feb; 25(2):140-149. PubMed ID: 32043775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.
    Alrabadi NN; Abushukair HM; Ababneh OE; Syaj SS; Al-Horani SS; Qarqash AA; Darabseh OA; Al-Sous MM; Al-Aomar SR; Ahmed YB; Haddad R; Al Qarqaz FA
    Clin Transl Oncol; 2021 Sep; 23(9):1885-1904. PubMed ID: 33877531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer.
    Wahl RU; Leijs M; Araujo A; Rübben A
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
    Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
    Front Immunol; 2020; 11():2105. PubMed ID: 33013886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma and Immune Checkpoint Inhibitors.
    Furue M; Ito T; Wada N; Wada M; Kadono T; Uchi H
    Curr Oncol Rep; 2018 Mar; 20(3):29. PubMed ID: 29569208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of eosinophilic granulocytes in women with infertility and pelvic adhesions.
    Edelstam G; Fredens K; Venge P
    Inflammation; 1994 Aug; 18(4):361-71. PubMed ID: 7982727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.